Tag - RevBio

Pitt researchers’ work on bone growth heads to space

Antonette Ho2022-12-05T23:39:37-05:00What do a dentist, a super glue, and the International Space Station have in common? Not much normally, but starting Tuesday, they’ll begin a journey together to answer questions lying deep within our bones. Dr. Giuseppe Intini, Associate Professor of Periodontics and Preventive Dentistry at the University of Pittsburgh School of Dental Medicine, is a dentist whose research at the Center for Craniofacial Regeneration focuses on skeletal stem cells — the “master cells” of the skeletal system — and their ability...

Local company develops adhesive that could be game changer for bone fracture healing

Antonette Ho2022-12-05T22:46:19-05:00Local researchers believe they have developed an adhesive that could help broken bones heal faster. Lowell-based RevBio told 7NEWS they hope their biomaterial, “Tetranite,” can one day be used to treat osteoporosis or spinal fractures. The adhesive is being developed to help bond fractures and fill gaps as new bone material grows. An injectable product that creates a robust bond in minutes, the company hopes Tetranite can also come in handy when it comes to healing bone lost in surgeries...

Novel Bone Adhesive to Fly on SpaceX CRS-26

Antonette Ho2022-12-05T23:42:54-05:00More than 200 million people worldwide are affected by osteoporosis, a crippling bone disease that decreases bone density, causing bones to weaken and become increasingly susceptible to fracture. Researchers from RevBio, a biomedical startup, are turning to the microgravity environment of the International Space Station (ISS) National Laboratory to further the development of a novel therapeutic that could help repair bone fractures. Read more >>

RevBio Receives NIH Grant to Explore the Treatment of Vertebral Compression Fractures with Its Regenerative Bone Adhesive Technology

Ziad2022-11-25T13:59:44-05:00RevBio, Inc., announced that it has been awarded a Phase I Small Business Innovation Research (SBIR) grant from the National Institute on Aging, part of the National Institutes of Health. This funding will allow the company to pursue the treatment of vertebral compression fractures with its patented bone adhesive technology known as Tetranite®. Because the osteoconductive bone adhesive is injectable, the material may be delivered in a minimally invasive procedure. Read more >>

RevBio Receives Approval from the U.K.’s Regulatory Authority to Initiate a Clinical Trial for an Optimized Formulation of its Dental Bone Adhesive Biomaterial

Ziad2022-11-25T13:59:44-05:00RevBio, Inc., announced that it has received approval from the Medicines and Healthcare products Regulatory Agency in the United Kingdom to start a 15-patient clinical trial to examine the safety and efficacy of immediately stabilized dental implants following tooth extractions using an optimized formulation of Tetranite®, the company’s bone adhesive biomaterial. RevBio has optimized its bone adhesive biomaterial primarily by adjusting the pH of the material as it undergoes its self-setting reaction. In addition, the company has also increased the...

RevBio Looked Below the Ocean for a Novel Way to Treat Bone Fractures

Ziad2022-11-25T14:00:11-05:00With nearly two decades as an engineer in the medical device industry under his belt, Brian Hess, CEO of RevBio and co-inventor of Tetranite bone adhesive technology, has long held a palpable fascination with biomaterials. Read more >>

RevBio Receives a $2 Million NIH Grant to Pursue the Treatment of Wrist Fractures with Its Innovative Bone Adhesive Technology

Ziad2022-12-05T23:40:58-05:00 RevBio, Inc., announced that it has been awarded a Phase II Small Business Innovation Research (SBIR) grant expected to total $2 million over two years from the National Institute on Aging, part of the National Institutes of Health. This funding will allow the company to pursue the treatment of wrist fractures with its patented bone adhesive technology known as Tetranite®. Read more >>

RevBio Awarded Funding to Conduct an In Vivo Bone Experiment on the International Space Station

Ziad2022-12-05T23:41:31-05:00 RevBio, Inc., announced that it has been awarded the opportunity to conduct an in vivo research experiment on the International Space Station U.S. National Laboratory (ISS National Lab). Read more >>

Sealing the Deal – Using Bone Glue to Treat Pain from Wisdom-Tooth Extractions

Ziad2022-12-05T23:41:19-05:00 For many teens, having one or more wisdom teeth removed is a health milestone after the first third molar teeth come in at the very back of the mouth and there isn’t enough room for them. But with this milestone also often comes another one – their first exposure to opioids. “Of about 10 million wisdom-tooth extractions done in a year, about a third come with a prescription for an opioid,” says George Kay, D.M.D., Chief Scientific Officer at the...

RevBio Enters the Animal Health Market to Help Improve Canine Dental Care

Ziad2022-12-05T23:41:36-05:00 As its first veterinary application, RevBio, Inc. announced that it has initiated a clinical study to validate the use of its innovative bone adhesive biomaterial to fill tooth extraction sockets in dogs in order to improve healing, maintain and support jaw thickness, and restore the structural stability which may help resist potential mandibular fractures. Read more >>